Microbial Etiology of Ventilator-associated Pneumonia in COVID-19 Infected Patients

• Conditions: Ventilator Associated Pneumonia
• Interventions: Other: Bacterial species isolated

• Registration Number: NCT04344509
• Lead Sponsor: Poitiers University Hospital

Brief Summary

National multicentric observational retrospective case-control study comparing the relative frequency of the various microorganisms responsible for VAP in patients infected or not by SARS-CoV-2 and their resistance to antibiotics.

Detailed Description

Not available

Study Timeline

• Status Verified: 2020-04
• Study First Submitted: 2020-04-10
• Study First Submitted QC: 2020-04-10
• Study First Posted: 2020-04-14
• Last Update Submitted: 2020-05-29
• Study Start: 2020-06
• Last Update Posted: 2020-06-02
• Primary Completion: 2020-09
• Study Completion: 2020-12

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: All
• Target Recruitment: 10000

Inclusion Criteria

• All patients with microbiologically confirmed VAP with pulmonary samples collected from March 15 to April 15 in France.

Exclusion Criteria

• All patients with microbiologically confirmed VAP with pulmonary samples collected from March 15 to April 15 in France.

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Arm && Interventions

Group	Intervention	Description
COVID19-positive patients	Bacterial species isolated	-
COVID19-negative patients	Bacterial species isolated	-

Primary Outcome Measures

Name	Time	Method
Prevalence of the microorganisms responsible for VAP among patients infected or not by the SARS-CoV-2	1 month

Secondary Outcome Measures

Name	Time	Method
Prevalence of multi-drug resistant bacteria responsible for VAP among patients infected or not by the SARS-CoV-2	1 month